Clinical Trials on Unresectable Bladder Carcinoma in Canada
Total 1839 results
-
National Cancer Institute (NCI)WithdrawnUrothelial Carcinoma | Renal Pelvis and Ureter Urothelial Carcinoma | Bladder Carcinoma | Stage III Bladder Cancer AJCC v8 | Stage IVA Bladder Cancer AJCC v8 | Bladder Urothelial Carcinoma | Muscle Invasive Bladder Carcinoma | Stage II Bladder Cancer AJCC v8Canada
-
University Health Network, TorontoBladder Cancer CanadaRecruitingBladder Cancer | Bladder Urothelial CarcinomaCanada
-
University Health Network, TorontoCanadian Urological Association; Canadian Urologic Oncology Group; Bladder Cancer...TerminatedBladder Cancer | Bladder Urothelial CarcinomaCanada
-
University of British ColumbiaCanadian Urologic Oncology GroupCompletedTransitional Cell Carcinoma | Bladder CancerCanada
-
PfizerTerminatedUrinary Bladder Neoplasms | Bladder Cancer | Urothelial Carcinoma | Bladder TumorsCanada
-
AHS Cancer Control AlbertaCross Cancer InstituteCompletedBladder Carcinoma | Small Cell Carcinoma | Lung NeoplasmCanada
-
John LenehanNot yet recruitingUnresectable or Metastatic Advanced Pancreatic Ductal AdenocarcinomaCanada
-
Pierre Fabre MedicamentBristol-Myers SquibbCompletedBladder Cancer | Bladder Neoplasms | Transitional Cell Carcinoma of the Urothelial TractCanada
-
National Cancer Institute (NCI)CompletedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Regional Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage III Bladder Cancer | Stage IV Bladder Cancer | Transitional...Canada
-
Sesen Bio, Inc.CompletedUrinary Bladder Cancer | Bladder Cancer | Bladder Neoplasms | Bladder TumorsUnited States, Canada
-
University Health Network, TorontoRecruitingLocally Advanced Pancreatic Adenocarcinoma | Unresectable Pancreatic Cancer | Pancreatic Adenocarcinoma Non-resectableCanada
-
University of British ColumbiaCompletedUnresectable Hepatocellular Carcinoma | Undergoing Chemoembolization and RadioembolizationCanada
-
Ontario Clinical Oncology Group (OCOG)Cancer Care OntarioActive, not recruitingMuscle-invasive Bladder CancerCanada
-
Sir Mortimer B. Davis - Jewish General HospitalCancer Research NetworkTerminatedLower Urinary Tract Symptoms | Bladder Carcinoma | BCGCanada
-
CHU de Quebec-Universite LavalCanadian Institutes of Health Research (CIHR)RecruitingNon-Muscle Invasive Bladder CancerCanada
-
London Health Sciences CentrePacific Edge LimitedUnknown
-
Lawson Health Research InstituteRecruitingNon-small Cell Lung Cancer Stage IB (Resectable) | Non-small Cell Lung Cancer Stage II (Resectable) | Non-small Cell Lung Cancer Stage ⅢA (Resectable)Canada
-
University of British ColumbiaWithdrawnBladder Cancer | High-Risk Cancer | Durvalumab | Non-muscle Invasive | TremelimumabCanada
-
Cell GenesysUnknownCarcinoma, Transitional Cell | Bladder NeoplasmsUnited States, Canada
-
Astellas Pharma Global Development, Inc.Seagen Inc.RecruitingCarcinoma in Situ | Urinary Bladder Neoplasms | Non-muscle Invasive Bladder Cancer | Carcinoma Transitional Cell | NMIBCUnited States, Canada, France, Spain, United Kingdom, Germany
-
QED Therapeutics, Inc.Helsinn Healthcare SATerminatedUpper Tract Urothelial Carcinomas | Urothelial Bladder CancerUnited States, France, Canada, Spain, Italy, Belgium, Germany, Netherlands, United Kingdom, Bulgaria, Greece
-
University Health Network, TorontoNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Urothelial Carcinoma | Stage III Bladder Cancer AJCC v8 | Stage IV Bladder Cancer AJCC v8 | Locally Advanced Urothelial CarcinomaUnited States, Canada
-
British Columbia Cancer AgencyBC Cancer Foundation; Pancreatic Cancer CanadaUnknownResectable Pancreatic Ductal AdenocarcinomaCanada
-
Incyte CorporationTerminatedMetastatic Urothelial Carcinoma | Unresectable Urothelial CarcinomaSpain, France, United States, Italy, Japan, Ireland, Slovakia, Austria, Belgium, Canada, Finland, Germany, Poland, Portugal, Romania, United Kingdom
-
National Cancer Institute (NCI)Canadian Cancer Trials GroupActive, not recruitingAtezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder CancerRecurrent Bladder Urothelial Carcinoma | Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage I Bladder Urothelial Carcinoma AJCC v6 and v7United States, Canada
-
University Health Network, TorontoAstraZeneca; Mirati Therapeutics Inc.WithdrawnSquamous Cell Carcinoma, Head And Neck | Squamous Cell Carcinoma Mouth | Resectable Squamous Cell Carcinoma of Oral CavityCanada
-
Fidia Farmaceutici s.p.a.RecruitingBladder Carcinoma in Situ (CIS)United States, Spain, Italy, France, Poland
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedUnresectable Hepatocellular CarcinomaBelgium, Italy, United States, Germany, Canada
-
Bernie EiglLady Davis Institute; Vancouver Prostate Centre; Bladder Cancer CanadaRecruitingMetastatic Urothelial Carcinoma | Metastatic Bladder CancerCanada
-
Western University, CanadaCompletedBladder Cancer | Hematuria | Bladder DiseaseCanada
-
McGill University Health Centre/Research Institute...CompletedUrinary Bladder Cancer | Bladder Cancer | Entire Ileal ConduitCanada
-
Bristol-Myers SquibbPierre Fabre MedicamentCompletedKidney Neoplasms | Transitional Cell Carcinoma | Bladder Cancer | Bladder Neoplasms | Ureter Neoplasms | Neoplasm, BladderUnited States, Spain, Italy, Canada, Indonesia, Singapore, Australia, Austria, France, Greece, Korea, Republic of, Philippines, Sweden, Switzerland, Thailand
-
University of Western Ontario, CanadaCompletedNeuroendocrine Carcinoma (Carcinoid)Canada
-
Ottawa Hospital Research InstituteTerminatedPancreatic Carcinoma Non-resectableCanada
-
University of SaskatchewanSaskatchewan Health Research FoundationWithdrawn
-
Ottawa Hospital Research InstituteTerminated
-
London Health Sciences CentreUnknown
-
NCIC Clinical Trials GroupTerminatedBladder CancerCanada
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedMetastatic or Locally Advanced Unresectable Solid TumorsUnited States, Canada
-
Lawson Health Research InstituteCompletedNeurogenic BladderCanada
-
Mansoura UniversityRecruitingNon-Muscle Invasive Bladder CancerEgypt
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaCompleted
-
Lawson Health Research InstituteTerminated
-
Boston Scientific CorporationBiocompatibles UK LtdCompletedUnresectable Hepatocellular CarcinomaKorea, Republic of, United States, Spain, France, United Kingdom, Canada, Germany, Singapore, Netherlands, Belgium, Italy
-
Unity Health TorontoCompletedOveractive BladderCanada
-
Lawson Health Research InstituteCompleted
-
Theralase Inc.University Health Network, Toronto; WCCT Global; Medelis Inc.CompletedNon-Muscle Invasive Bladder Cancer (NMIBC) Refractory to BCGCanada
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyRecruitingMetastatic or Locally Advanced Unresectable Solid TumorsUnited States, Canada, Spain